Andrew J Sharp, PhD Email Andrew Sharp
- ASSOCIATE PROFESSOR | Genetics and Genomic Sciences
Mar 2018 - present – Member, Icahn Institute for Data Science and Genomic Technology, Mount Sinai School of Medicine, New York, USA
Mar 2010 - present – Associate Professor, Department of Genetics and Genomics, Mount Sinai School of Medicine, New York, USA
October 2007 - March 2010: Marie Curie Fellow in laboratory of Stylianos Antonarakis, Department of Genetic Medicine, University of Geneva, Switzerland
January 2004 - September 2007: Senior Fellow in laboratory of Evan Eichler, Department of Genome Sciences, University of Washington, Seattle. Studying structural variation of the human genome and genomic disorders
October 2002 - December 2003: Research Assistant, Wessex Regional Genetics Laboratory, Salisbury, UK
September 1997 - September 2002: PhD Student, University of Southampton, England. Supervisor Prof. Patricia Jacobs. Thesis entitled ‘Molecular Studies of X Chromosome Inactivation in Humans’, Division of Human Genetics,
January 1997 - October 1999: Research Technician, Wessex Regional Genetics Laboratory, Salisbury, UK
Alzheimer's Disease, Bioinformatics, Epigenetics, Gene Expressions, Gene Regulation, Genetics, Genomics, Microarray, Multiple Sclerosis
Multi-Disciplinary Training Area
Genetics and Data Science [GDS]
BSc, University of Exeter
PhD, University of Southampton
Young Investigator Award for Outstanding Science
European Society of Human Genetics
Trainee Award (postdoctoral)
American Society of Human Genetics
Trainee Award (predoctoral)
American Society of Human Genetics
The Sharp lab is an integrated research environment combining both experimental and bioinformatic approaches. My research uses genomic approaches to study the human genome and disease, utilizing a strategy that can be described as 'reverse genetics'. The theory behind this idea is that rather than studying a specific condition, we use a bottom-up approach using high-throughput techniques to study various aspects of the human genome, and then link these observations to different diseases.
My lab therefore performs global analyses of structural variation, epigenetics, and gene expression combining innovative experimental and bioinformatic approaches. We use both wet lab technologies such as DNA microarrays and high-massively parallel sequencing in addition to performing computational analyses of the human genome, and large datasets produced by high-throughput technologies.
What can this approach do? During my postdoctoral work, I developed custom microarrays to study structural variation of the human genome. By first analyzing the human genome computationally, we identified regions that had a structure that suggested they might render them unstable and prone to frequent rearrangement. By focusing our studies on these regions, we were then able to identify many new genetic syndromes that together account for ~2% of cases of mental retardation worldwide, and also act as susceptibility factors for autism, schizophrenia and diabetes. One also represents the most common genetic risk factor for epilepsy identified to date.
More recently we have developed genome-wide technologies for analyzing DNA methylation, an epigenetic modification that controls how genes are switched on and off. By comparing methylation patterns in healthy and diseased patients, we can discover what parts of the genome regulate patterns of gene expression, hence identifying the important functional elements that are now excellent candidates for human disease. Other projects I am developing seek to study the role of tandem repeat DNA in the human genome, utilize patterns of gene expression as a tool to uncover genes regulating human phenotypes, and investigate epigenetic changes in diseases including multiple sclerosis, Alzheimer's disease, and neural tube defects.
My work has been published repeatedly in top journals such as Nature Genetics and The New England Journal of Medicine. I also have the unique achievement of receiving the Young Investigator Award for Outstanding Science from the European Society of Human Genetics, and the Trainee Award from the American Society of Human Genetics on two different occasions.
I am a co-Director of the Graduate Program in Genetics and Genomic Sciences, and also course director for two graduate courses: BSR2400, a 2-credit course entitled “Translational Genomics” that gives an overview of diverse topics in modern genetics/genomics, and BSR4401, the “Genetics andGenomics Journal Club”.
I welcome the opportunity to teach bright students with an interest in learning novel approaches to the study of the human genome. I can offer a diverse environment and the opportunity to gain exposure to many productive and innovative areas of research in human genetics and genomics. Computational skills are a definite advantage, but are not required. If you are interested in learning more about my research please contact me at firstname.lastname@example.org
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Sharp during 2020 and/or 2021. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
- Coleman Research Group
- Gerson Lehrman Group
- Guidepoint Global, LLC.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.